AFWM
EDIT icon

Abich Financial Wealth Management’s Editas Medicine EDIT Stock Holding History

Abich Financial Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$42 Buy
+12
New +$33 ﹤0.01% 651
2024
Q3 		– Sell
-12
Closed -$56 – 515
2024
Q2 		$56 Hold
12
– – ﹤0.01% 789
2024
Q1 		$89 Hold
12
– – ﹤0.01% 532
2023
Q4 		$122 Buy
+12
New +$105 ﹤0.01% 439

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Abich Financial Wealth Management's EDIT Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Editas Medicine (EDIT) in Q3 2025: 12 shares worth $42. The stake represents ﹤0.01% of the portfolio and ranks #651 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in EDIT as recently as Q2 2024.

Abich Financial Wealth Management first reported a position in EDIT in Q4 2023 and has held it in 4 quarters since. The position peaked at $122 in Q4 2023. 194 funds tracked by Wall St. Rank hold EDIT as of Q3 2025.

  • Abich Financial Wealth Management held 12 shares of Editas Medicine worth $42 as of Q3 2025.
  • Editas Medicine was a new Abich Financial Wealth Management position in Q3 2025.
  • Editas Medicine made up ﹤0.01% of Abich Financial Wealth Management's portfolio in Q3 2025, its #651 holding.
  • Abich Financial Wealth Management first reported a position in Editas Medicine in Q4 2023 and has held it in 4 quarters since.
  • Abich Financial Wealth Management's Editas Medicine position peaked at $122 in Q4 2023.
  • 194 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.